Stuart Lipton, MD, PhD, is a board-certified neurologist who specializes in neurodegenerative diseases. A neuroscientist and world-renowned expert in dementia, Dr. Lipton is best known for developing the FDA-approved memantine (Namenda, NamendaXR, Namzaric), the first drug in a novel class of medications used to treat moderate-to-severe Alzheimers disease.In addition to his clinical practice in ge… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Pennsylvania School of Medicine | Medical Degree | Medical Degree | Not Specified |
| Neurologist | Medical Degree | Medical Degree | Not Specified |
| Adjunct Professor of Neurosciences | Medical Degree | Medical Degree | Not Specified |
| Certification | Cert. Body | Year |
|---|---|---|
| Psychiatry and Neurology | 1982 |
Stuart Lipton, MDPHD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes
